TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/16/2026
Back to search
Official data from USPTO
IMMUNOTHERAPY IN ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOTHERAPY IN ONCOLOGY
ST13
US500000097154897Class
16
Filing
97154897
Registration
7281228
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/18/2026
Trademark type
Word
Nice classes
16
Filing date
12/03/2021
Registration date
01/16/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/16/2024
Last transaction
03/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
2011-06-00
First use in commerce
06/01/2023
Drawing code
4
Owner type
16
Owner location
Langhorne, PA, US
Examiner
ROTH, BENJAMIN H.
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Lynx Group, LLC
The Lynx Group, LLC
Representatives
Brian L. Petrequin, Esq. Greenberg Traurig LLP
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed publicationspeer-reviewed medical magazinesjournalsnewslettersfeature reportsmonographsprinted supplements to the foregoing in the fields of immunologyhematologyoncology and cancer
Publications
History of USPTO decisions and trademark events.
32 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/16/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/16/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/16/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/16/2026
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/22/2024
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/17/2024
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/16/2024
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/16/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
08/02/2023
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/01/2023
IUAA
USE AMENDMENT ACCEPTED
08/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/24/2023
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
07/24/2023
IUAF
USE AMENDMENT FILED
07/24/2023
EAAU
TEAS AMENDMENT OF USE RECEIVED
07/22/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/21/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/21/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/24/2023
GNFR
FINAL REFUSAL E-MAILED
01/24/2023
CNFR
FINAL REFUSAL WRITTEN
01/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/26/2022
GNRT
NON-FINAL ACTION E-MAILED
01/26/2022
CNRT
NON-FINAL ACTION WRITTEN
01/26/2022
DOCK
ASSIGNED TO EXAMINER
01/19/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/07/2021
NWAP
NEW APPLICATION ENTERED
12/07/2021
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOTHERAPY IN ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.